Antinuclear antibodies (ANAs) are a diverse group of autoantibodies that recognize nuclear macromolecules and their complexes. ANAs represent key biomarkers in the evaluation of rheumatic diseases, ...
NEW YORK, June 1, 2021 /PRNewswire/ -- The antinuclear antibody (ANA) testing market is expected to grow by USD 362.30 million during 2021-2025, according to Technavio. The report offers a detailed ...
Please provide your email address to receive an email when new articles are posted on . Although testing for antinuclear antibodies is widely viewed as an effective screening tool for lupus and other ...
(MENAFN- GlobeNewsWire - Nasdaq) Key market opportunities for the Antinuclear Antibody (ANA) Testing industry include rising autoimmune disease cases boosting demand, technological advances enhancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback